Hypertensive intracerebral hemorrhage (HICH) is a cerebrovascular disease caused by the rupture of arteries, veins or capillaries in the brain due to hypertension, resulting in a series of clinical symptoms. Hypertensive cerebral hemorrhage is a global disease with high morbidity, disability and mortality, and is both a common and serious health hazard. Hemorrhage in the nucleus accumbens and basal ganglia is the most common site of hypertensive cerebral hemorrhage, mostly damaging the internal capsule. Patients present with sudden severe headache, mostly accompanied by agitation, drowsiness or coma. When the hematoma expands and the cerebral edema increases, the intracranial pressure increases, causing brain herniation crisis such as dilated pupils on the side of the hematoma, respiratory impairment, slowed pulse rate and elevated blood pressure, which then turns into central failure. Hypertensive cerebral hemorrhage has a rapid onset and progresses rapidly, and can be life-threatening if left untreated. At present, the treatment of hypertensive cerebral hemorrhage depends on the amount of hemorrhage. For lesser hemorrhage, conservative medical treatment can be adopted; for larger hematoma, craniotomy or stereotactic brain surgery is required to remove the hematoma in time to relieve the brain pressure and promote recovery. Brain stereotactic hematoma aspiration is precise in positioning and has little surgical damage, and is especially suitable for hematoma removal in deep brain or important functional areas.